HOME >> BIOLOGY >> NEWS
Joslin President awarded medal from international diabetes organization

BOSTON - C. Ronald Kahn, M.D., President and Director of Joslin Diabetes Center, has been awarded the 2004 Claude Bernard Medal by the European Association for the Study of Diabetes (EASD) at the organization's 40th Annual Meeting in Munich, Germany. This prestigious award recognizes innovative leadership and superior contributions in the field of diabetes research and is the highest scientific honor awarded by the EASD. Dr. Kahn also is the Mary K. Iacocca Professor of Medicine at Harvard Medical School.

As part of the honor, Dr. Kahn presented the distinguished Claude Bernard Lecture, considered to be the highlight of the weeklong EASD annual meeting, which was held Sept. 5-9. Dr. Kahn discussed how communication between the brain and tissues of the body relates to the pathogenesis of diabetes. Dr. Ele Ferrannini, the president of the EASD, presented Dr. Kahn with the Claude Bernard Medal immediately following his lecture on the final day of the meeting, Sept. 9.

Over the past three decades, the research of Dr. Kahn has literally defined the field of insulin signal transduction and mechanisms of altered signaling in disease. In 1981, Dr. Kahn's laboratory discovered that the insulin receptor is an insulin-stimulated enzyme with protein tyrosine kinase activity. His laboratory also demonstrated how insulin signaling is altered in insulin-resistant states, such as type 2 diabetes and obesity; the impact of genetics and environment on these signaling functions; and how knowledge gleaned from these studies can be translated into new treatment methods for people with diabetes.

In recent studies, Dr. Kahn and his colleagues have conducted a series of studies using genetically engineered mice with knocked out insulin receptors in classical target tissues, such as liver, muscle and fat. These experiments indicated the important link between obesity, diabetes and longevity. Using these techniques, Dr. Kahn and collea
'"/>


10-Sep-2004


Page: 1 2 3

Related biology news :

1. Joslin Diabetes Center honors brothers living 70-plus years with type 1 diabetes
2. Joslin researchers clarify mechanisms for beta-cell formation
3. Joslin Diabetes Center adds first affiliate in California at Irvine Medical Center
4. New imaging technology at Joslin shown to detect early signs of type 1 diabetes
5. Joslin Diabetes Center launches research section on developmental and stem cell biology
6. Joslin Diabetes Center releases new low impact exercise video
7. Joslin researchers identify key molecule in Type 1 diabetes progression
8. As obesity skyrockets, Joslin Diabetes Center urges action to stem the tide of type 2 diabetes
9. AAAS US Presidential Candidates Forum
10. US Presidential Candidates Forum
11. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/4/2020)... ... July 03, 2020 , ... Aesthetics Biomedical (ABM), a leading ... for not only the products and treatments developed, but also the dedicated team ... All the brands built by ABM have received several honors already for 2020, ...
(Date:6/28/2020)... ... June 25, 2020 , ... Genedata, ... that it has entered into a multi-year contract with Merus N.V., a ... translational and clinical research strategy to discover and develop ground-breaking drugs. The ...
(Date:6/23/2020)... ... ... The field of quantitation of large molecules or proteins has been around ... the use of mass spectrometry in this field has gained a lot of momentum ... choose which approach to use (LBA or MS)?” In many cases, either technology ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... August 13, 2020 , ... Inc. magazine ... the most prestigious ranking of the nation’s fastest-growing private companies. The list represents ... dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many ...
(Date:8/7/2020)... ... August 06, 2020 , ... ... industries, announces it has closed on the purchase of greenfield for a new, ... TX and includes over 21 acres in the initial acquisition, with an option ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... today announced the launch of its new tagline, “BUILDING FOR LIFE.” The adoption ... industry and around the globe, requiring fast track capacity to provide patients with ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... eSource has ... inefficiencies. This webinar will cover the history of eSource, the reasons it did not ... EMR/EHR to wearables, to site source, the industry is moving towards capturing data electronically ...
Breaking Biology Technology:
Cached News: